Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting
December 09, 2019 11:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting...
Aptose Biosciences Submits IND Application for CG-806
February 25, 2019 07:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that it has submitted an Investigational New...